Pfizer and SINOPHARM have entered into a new partnership to promote antifungal drug Diflucan in China. The collaboration also includes plans to work together on future Pfizer product launches in the ...

Pfizer is drawing renewed market attention as healthcare strength, pharmaceutical deal activity, and defensive demand reshape ...

Pfizer’s valuation story turns to pipeline progress, oncology pressure, earnings strength, and healthcare execution after a ...

For the second consecutive year, Pfizer is advertising at the Super Bowl. The pharma giant announced Friday morning that it is doubling down on its fight against cancer with a 60-second ad set to air ...

July 30 (Reuters) - Pfizer (PFE.N), opens new tab raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its heart ...

As its lead candidate advances into a late-stage trial for pulmonary arterial hypertension (PAH), Inhibikase Therapeutics has picked up a commercial leader with plenty of experience in the PAH space.

By Maggie Fick BRUSSELS, June 23 (Reuters) - China has pulled ahead of Europe in pharmaceutical innovation and drug ...

The setback dims the outlook for a medicine Pfizer sees as an important contributor going forward, though some analysts are ...